Gyre Therapeutics, Inc. (GYRE) Insider Trading

Over the last 3 months, GYRE insiders made 0 open-market buys and 9 sales, a net sale of -$462K (SEC Form 4). Over the last 6 months, 41 institutions increased and 18 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$461.6K
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
May
May
Context3-month price -20.9%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 27, 2026Ye Weiguoofficer: Chief Operating OfficerOption4,000$0.75
May 27, 2026Ye Weiguoofficer: Chief Operating OfficerOption3,500$0.75
May 27, 2026Ye Weiguoofficer: Chief Operating OfficerSell3,500$6.08
May 27, 2026Ye Weiguoofficer: Chief Operating OfficerSell4,000$6.10
May 22, 2026Ye Weiguoofficer: Chief Operating OfficerOption9,400$0.75
May 22, 2026Ye Weiguoofficer: Chief Operating OfficerSell12,820$6.15
May 22, 2026Ye Weiguoofficer: Chief Operating OfficerOption12,820$0.75
May 20, 2026Ye Weiguoofficer: Chief Operating OfficerOption200$0.75
May 20, 2026Ye Weiguoofficer: Chief Operating OfficerSell200$6.62
May 20, 2026Ye Weiguoofficer: Chief Operating OfficerOption9,120$0.75
May 20, 2026Ye Weiguoofficer: Chief Operating OfficerSell9,120$6.37
May 18, 2026Ye Weiguoofficer: Chief Operating OfficerOption15,580$0.75
May 18, 2026Ye Weiguoofficer: Chief Operating OfficerOption13,100$0.75
May 18, 2026Ye Weiguoofficer: Chief Operating OfficerSell13,100$6.65
May 18, 2026Ye Weiguoofficer: Chief Operating OfficerSell15,580$6.91
May 7, 2026Luo Yingdirector, officer: Chief Executive OfficerSell10,136$8.04
May 7, 2026Luo Yingdirector, officer: Chief Executive OfficerSell179$8.01
May 6, 2026Eastling Thomas Wilsonofficer: Chief Financial OfficerGrant47,530$0.93
May 6, 2026Eastling Thomas Wilsonofficer: Chief Financial OfficerGrant92,683$5.98
May 6, 2026Eastling Thomas Wilsonofficer: Chief Financial OfficerGrant33,271$2.00
May 6, 2026Eastling Thomas Wilsonofficer: Chief Financial OfficerGrant11,882$2.00
May 6, 2026Eastling Thomas Wilsonofficer: Chief Financial OfficerGrant95,060$0.32
Jan 9, 2026Zhang PingdirectorGrant100,000$7.31
Jan 9, 2026Chen Ruoyuofficer: Chief Financial OfficerGrant50,000$7.31
Aug 26, 2025Weng DandirectorGrant52,000$7.85
Aug 7, 2025Zhang PingdirectorGrant250,000$6.92
Jun 6, 2025Parry RenatedirectorGrant26,000$8.58
Jun 6, 2025Epstein David M.directorGrant26,000$8.58
Jun 6, 2025Eastling Thomas WilsondirectorGrant26,000$8.58
Jun 6, 2025Nussbaum Rodney LdirectorGrant26,000$8.58

Source: GYRE SEC Form 4 filings, latest May 27, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their GYRE positions over the last 6 months (SEC Form 13F).

Increased
41
New positions
18
Reduced
18
Sold out
9
Largest moves
InstitutionActionSharesFiled
VANGUARD GROUP INCIncreased1.2MJan 29, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position984KMay 15, 2026
BLACKROCK, INC.Increased759KMay 13, 2026
BLACKROCK, INC.Increased720KFeb 12, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased431KMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased423KFeb 9, 2026
STATE STREET CORPIncreased216KMay 15, 2026
STATE STREET CORPIncreased202KFeb 13, 2026
SBI SECURITIES CO., LTD.Increased171KApr 28, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INCIncreased169KFeb 13, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INCReduced165KMay 15, 2026
SBI SECURITIES CO., LTD.Reduced163KFeb 3, 2026
VANGUARD FIDUCIARY TRUST CONew Position138KMay 8, 2026
NORTHERN TRUST CORPIncreased134KMay 14, 2026
NORTHERN TRUST CORPIncreased129KFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.